Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens (Q38078878)

28 August 2017

Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens (English)

1 reference

28 August 2017

Gram-negative bacteria

0 references

urinary tract infection

1 reference

Matthew E Levison

1

1 reference

PubMed ID

23378123

28 August 2017

Donald Kaye

series ordinal

2

1 reference

28 August 2017

1 April 2013

1 reference

Current infectious disease reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

109-115

1 reference

28 August 2017

2

1 reference

Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria

28 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Carbapenemases: the versatile beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

NDM-1-producing Klebsiella pneumoniae resistant to colistin in a French community patient without history of foreign travel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Bacteriuria localization and response to single-dose therapy in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Empirical use of ciprofloxacin for acute uncomplicated pyelonephritis caused by Escherichia coli in communities where the prevalence of fluoroquinolone resistance is high

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Effectiveness and safety of colistin: prospective comparative cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Revisiting "older" antimicrobials in the era of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Excess deaths associated with tigecycline after approval based on noninferiority trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0315-7

Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012

21 January 2018

1 reference

12 December 2020

Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.

1 reference

12 December 2020

Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae

1 reference

12 December 2020

Complicated urinary tract infections

1 reference

12 December 2020

Duration of therapy for urinary tract infection: the long and the short of it

1 reference

12 December 2020

Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.

1 reference

12 December 2020

Complicated urinary tract infection in adults

1 reference

12 December 2020

10.1007/S11908-013-0315-7

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23378123